Home/Filings/4/0000891839-21-000138
4//SEC Filing

Yanni Barbara 4

Accession 0000891839-21-000138

CIK 0001205922other

Filed

May 11, 8:00 PM ET

Accepted

May 12, 4:25 PM ET

Size

9.4 KB

Accession

0000891839-21-000138

Insider Transaction Report

Form 4
Period: 2021-05-11
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-05-11+28,58628,586 total
    Exercise: $2.15From: 2022-05-11Common Stock (28,586 underlying)
Holdings
  • Stock Option (Right to Buy)

    Exercise: $7.78From: 2020-05-15Common Stock (7,718 underlying)
    7,718
  • Stock Option (Right to Buy)

    Exercise: $3.95From: 2021-05-14Common Stock (15,679 underlying)
    15,679
  • Stock Option (Right to Buy)

    Exercise: $13.60Exp: 2027-09-15Common Stock (6,396 underlying)
    6,396
Footnotes (4)
  • [F1]Exercisable in full as of the date of this report.
  • [F2]This option expires on May 14, 2029 or five years following retirement or cessation of services, whichever occurs first.
  • [F3]This option expires on May 12, 2030 or five years following retirement or cessation of services, whichever occurs first.
  • [F4]This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 9, 2031 or five years following retirement or cessation of services, whichever occurs first.

Issuer

VACCINEX, INC.

CIK 0001205922

Entity typeother

Related Parties

1
  • filerCIK 0001610561

Filing Metadata

Form type
4
Filed
May 11, 8:00 PM ET
Accepted
May 12, 4:25 PM ET
Size
9.4 KB